NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Stopped Poor accrual; Avastin refractory patients not feasible given treatment paradigm in these patients.

Conditions

• Glioblastoma
• Brain Neoplasms

Interventions

• DEVICE: NovoTTF-100A
• PROCEDURE: Quality-of-life assessment
• GENETIC: Laboratory biomarker analysis

Sponsor

University of Florida

Collaborators

• [object Object]
• [object Object]